This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
12 - 14 Nov 2024
Hamburg Congress CentreHamburg, Germany

El Djouhar Rekai, PhD
Head of Peptide Process Development and Manufacturing LCM at PolyPeptide Group
Speaker

Profile

Dr. Rekaï is Head of Process Development & Manufacturing Life Cycle Management, at PolyPeptide Group in Belgium, in charge of the R&D, scaling-up, validation and commercial process of the peptide projects. She obtained her PhD in Organic Chemistry (Sugar chemistry) from University of Pierre and Marie Curie in 1997. Then, she took up a post-doctoral position in Polymer chemistry at the University Catholique de Louvain in Belgium from 1998 to 1999. In January 2000, Dr. Rekaï started as peptide R&D Chemist at UCB-Bioproducts, Braine-l’Alleud (Belgium). Then, she specialized in chemical up scaling and validation before taking on the role of the overall Process Development and commercial stages in October 2013.

Agenda Sessions

  • Current Chemical Strategies in Extending Half-Lives of Therapeutic Peptides

    14:00